The field of cell and gene therapy (CGT) has made remarkable strides in recent years, offering new hope to patients across an increasingly wide range of conditions. However, the field’s growth has ...
Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy. Among RNA-based ...
In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim ...
Introgen Therapeutic’s (Austin, TX) p53-based INGN 225 cancer vaccine yielded promising safety and efficacy results in a Phase II trial in advanced small cell lung cancer. The personalized therapeutic ...
To solve a problem, scientists first need to see it clearly. Whether it’s a virus slipping past the immune system or plaques forming in the brain, visualization is the first step toward finding ...
Background: Toys in pediatric office waiting rooms may be fomites for transmission of viruses. Methods: Eighteen samples were taken from office objects on 3 occasions. Samples were tested for presence ...
RNA Fluorescence In Situ Hybridization reveals transcription at the LMO2 promoter for patients P4 (a) and P5 (b). In each case, an antisense LMO2 probe and an antisense c probe were hybridized to T ...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best mid cap growth stocks to invest in now. Earlier on June 4, Sarepta Therapeutics announced that the US FDA has granted Platform Technology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback